Two people can take the exact same dose of the exact same product and get wildly different blood levels based purely on how they administer it
6 Since then, states have altered their positions on covering anti-obesity GLP-1 therapies: Four have withdrawn coverage entirely (California, New Hampshire, Pennsylvania, and South Carolina), three have added coverage (Missouri, Tennessee, and Utah), and at least two states (Michigan and Virginia) have enacted more narrow utilization criteria, limiting future use to those with morbid obesity
The peptide has been slowly degrading over its entire shelf life, even under perfect refrigeration
This was inspired by prior GIP (glucose-dependent insulinotropic polypeptide) research, highlighting that besides GIP, other substances in the intestine also stimulate insulin secretion
For many treatment plans, your approved medication can be discreetly delivered right to your door
Common and Serious Side Effects The most frequent issues include nausea, vomiting, constipation, and diarrhea